Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-2.53M.
ENTERPRISE VALUE (EV)
$-2.53M
FibroBiologics, Inc. Common Stock
Market Cap
$2.37M
Enterprise Value (EV)
$-2.53M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.37M | $-2.53M |
| Onconetix, Inc. (ONCO)vs › | $2.37M | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | $2.48M |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | $12.50M |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | $1.54M |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | $12.50M |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A |
Market Cap
$2.37M
Total Debt
$0.00
Cash
$4.89M
Enterprise Value
$-2.53M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
